SPY769.86+0.03%QQQ749.55−0.00%BTC/USD85,838.40+1.29%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%
Benzinga

Michael Lavery

Michael Lavery is a prominent equity research analyst known for his coverage of consumer and retail companies. He has worked with leading financial institutions, delivering detailed market analysis, earnings forecasts, and investment recommendations. Lavery's expertise in evaluating industry trends and corporate performance makes him a key voice for institutional investors and market watchers.

Boston Beer Company: These 2 Beverages Have Diminished Their 2025 Outlook, Says Previously Bullish Analyst
Boston Beer Company: These 2 Beverages Have Diminished Their 2025 Outlook, Says Previously Bullish Analyst
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
Coca-Cola's Strong Exposure To Emerging Markets Is Key To Sustainable Growth, Says Bullish Analyst
Coca-Cola's Strong Exposure To Emerging Markets Is Key To Sustainable Growth, Says Bullish Analyst
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
Coca-Cola's Strong Exposure To Emerging Markets Is Key To Sustainable Growth, Says Bullish Analyst
Coca-Cola's Strong Exposure To Emerging Markets Is Key To Sustainable Growth, Says Bullish Analyst
Boston Beer Company: Hard Mountain Dew Is Still A Catalyst, 3 Analysts Cut Forecasts After Q2 Results
Boston Beer Company: Hard Mountain Dew Is Still A Catalyst, 3 Analysts Cut Forecasts After Q2 Results
3 Beer Stocks: What This Analyst Thinks Is Brewing
3 Beer Stocks: What This Analyst Thinks Is Brewing

Michael Lavery Recent News

Piper Sandler's Michael Lavery Shares Cannabis Industry Projections, Names 'The Real Key Catalyst To Watch'
Piper Sandler's Michael Lavery Shares Cannabis Industry Projections, Names 'The Real Key Catalyst To Watch'
The U.S. cannabis market has the potential to reach $115 billion by 2030, while last year regulated sales in the country have hit $17.5 billion, according to Michael Lavery, a director and senior research analyst covering consumer staples and cannabis for Piper Sandler.
Why This Beyond Meat Analyst Is Turning Bearish
Why This Beyond Meat Analyst Is Turning Bearish
Beyond Meat Inc’s (NASDAQ: BYND) momentum across retail channels falls short of consensus expectations, according to Piper Sandler. The Beyond Meat Analyst: Michael Lavery downgraded Beyond Meat from Neutral to Underweight and reduced the price target from $120 to $95.
Why Hershey's Stock Is Sweet For Investors
Why Hershey's Stock Is Sweet For Investors
Hershey Co (NYSE: HSY) is among the best-positioned food companies amid the surge in commodity costs as cocoa prices have remained stable, according to Piper Sandler.
Piper Sandler Likes Tyson Foods As A Reopening Play
Piper Sandler Likes Tyson Foods As A Reopening Play
Tyson Foods, Inc. (NYSE: TSN) could be considered an economic reopening play due to the company's large exposure to the foodservice category, according to Piper Sandler.
Beyond Meat Analysts Debate If The Stock Now Has Big Opportunity Or Major Headwinds
Beyond Meat Analysts Debate If The Stock Now Has Big Opportunity Or Major Headwinds
Plant-based food maker Beyond Meat Inc (NASDAQ: BYND) reported third-quarter earnings that notably fell short of expectations and sparked a debate among analysts.
Cannabis Analysts From Piper Sandler, Jefferies, Cowen On Their Favorite Companies, Investments
Cannabis Analysts From Piper Sandler, Jefferies, Cowen On Their Favorite Companies, Investments
Some of the most high-profile cannabis analysts shared their insights in a thrilling discussion about trends, strategies and forecasts at the Virtual Benzinga Cannabis Capital Conference. Alan Brochstein, the founder of 420 Investor and New Cannabis Ventures, led the discussion.
Hershey Analyst Turns Bullish As Retail Sales Rise
Hershey Analyst Turns Bullish As Retail Sales Rise
2 Beyond Meat Analysts On Q4 Results: 'Significant Downside Exists'
2 Beyond Meat Analysts On Q4 Results: 'Significant Downside Exists'
This Beyond Meat Consumer Survey Highlights Some Challenges, Analyst Says
This Beyond Meat Consumer Survey Highlights Some Challenges, Analyst Says
Analyst: Canopy Growth Can Outlast Near-Term Headwinds
Analyst: Canopy Growth Can Outlast Near-Term Headwinds
Potential No-Premium Deal Raises Questions On Altria's Outlook, This Analyst Moves Aside
Potential No-Premium Deal Raises Questions On Altria's Outlook, This Analyst Moves Aside
Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation'
Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation'
Piper Jaffray: Tilray, GW Pharma Are Early Leaders In Medical Cannabis
Piper Jaffray: Tilray, GW Pharma Are Early Leaders In Medical Cannabis
Piper Jaffray Sees More Upside In Canopy Growth On Geographic, Product Expansion
Piper Jaffray Sees More Upside In Canopy Growth On Geographic, Product Expansion
Piper Jaffray Out Bullish On Tilray, Canopy Growth, Says Global Cannabis Market Could Grow Tenfold
Piper Jaffray Out Bullish On Tilray, Canopy Growth, Says Global Cannabis Market Could Grow Tenfold
Kraft Heinz: Good M&A May Come To Those Who Wait
Kraft Heinz: Good M&A May Come To Those Who Wait
Cautious Call On Kellogg; Shares Downgraded On Risk To Shelf Space
Cautious Call On Kellogg; Shares Downgraded On Risk To Shelf Space
Philip Morris Looking To Regain Market Share In Indonesia With New Product
Philip Morris Looking To Regain Market Share In Indonesia With New Product
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved